Aug 1, 2016
Dr. Todd Brandt discusses PSA screening in African-American men , highlighting the need for greater screening within that population given the higher incidence of prostate cancer and the greater risk of more aggressive disease.
Link to New York Times Op-Ed piece:http://mobile.nytimes.com/2016/07/27/opinion/prostate-cancer-isnt-colorblind.html?smid=tw-share&_r=1&referer=
Quote from article:
"What’s needed, instead, is a smarter approach that incorporates the American Cancer Society’s recommendation that doctors and patients discuss the risks and benefits of PSA tests beginning at age 45 for African-American men, and at younger ages for men with a strong family history of prostate cancer."